Formyl peptide receptor suppresses melanoma development and promotes NK cell migration

Inflammation

Volumn 37, Issue 3, 2014, Pages 984-992

  Liu, Jian ^a   Li, Jun ^b   Zeng, Xiang ^c   Rao, Zhiguo ^a   Gao, Jianfei ^a   Zhang, Bicheng ^a   Zhao, Yong ^a   Yang, Bo ^a   Wang, Zhigang ^a   Yu, Lifang ^a   Wang, Weixing ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Central Hospital of the Yangtze River Shipping   (China)

Author keywords

ERK; FPR; melanoma; NK cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTINEOPLASTIC AGENT; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR AGONIST; FORMYLPEPTIDE RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; FLAVONOID; OLIGOPEPTIDE; PROTEIN KINASE INHIBITOR; TRP-LYS-TYR-MET-VAL-MET; TRYPTOPHYL-ARGINYL-TRYPTOPHYL-TRYPTOPHYL-TRYPTOPHYL-TRYPTOPHANAMIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL INFILTRATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNE SYSTEM; MELANOMA; MELANOMA CELL LINE; MOUSE; NATURAL KILLER CELL; NONHUMAN; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT; WILD TYPE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; MELANOMA, EXPERIMENTAL; METABOLISM; TUMOR CELL LINE; TUMOR ESCAPE;

MURINAE; MUS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; KILLER CELLS, NATURAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MYELOID CELLS; OLIGOPEPTIDES; PROTEIN KINASE INHIBITORS; RECEPTORS, FORMYL PEPTIDE; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84902547189     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9819-z     Document Type: Article

References (38)

1. Wakita, D., K. Sumida, Y. Iwakura, H. Nishikawa, T. Ohkuri, K. Chamoto, et al. 2010. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. European Journal of Immunology 40: 1927-1937.
2. Croci, D.O., M.F. Zacarias Fluck, M.J. Rico, P. Matar, G.A. Rabinovich, and O.G. Scharovsky. 2007. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunology, Immunotherapy : CII 56: 1687-1700.
3. Li, L., L.N. Liu, S. Feller, C.Allen, R. Shivakumar, J. Fratantoni, et al. 2010. Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method. Cancer Gene Therapy 17: 147-154.
4. Le, Y., J.J. Oppenheim, and J.M.Wang. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine & Growth Factor Reviews 12: 91-105.
5. Le, Y., Y. Yang, Y. Cui, H. Yazawa, W. Gong, C. Qiu, et al. 2002. Receptors for chemotactic formyl peptides as pharmacological targets. International Immunopharmacology 2: 1-13.
6. Gao, J.L., E.J. Lee, and P.M. Murphy. 1999. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. The Journal of Experimental Medicine 189: 657-662.
7. Chen, K., Y. Le, Y. Liu, W. Gong, G. Ying, J. Huang, et al. 2010. A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses. Journal of Immunology 184: 3331-3335.
8. French, A.R., and W.M. Yokoyama. 2003. Natural killer cells and viral infections. Current Opinion in Immunology 15: 45-51.
9. Wu, J., and L.L. Lanier. 2003. Natural killer cells and cancer. Advances in Cancer Research 90: 127-156.
10. Robertson, M.J. 2002. Role of chemokines in the biology of natural killer cells. Journal of Leukocyte Biology 71: 173-183.
11. Kim, S.D., J.M. Kim, S.H. Jo, H.Y. Lee, S.Y. Lee, J.W. Shim, et al. 2009. Functional expression of formyl peptide receptor family in human NK cells. Journal of Immunology 183: 5511-5517.
12. Liu, Y., K. Chen, C. Wang, W. Gong, T. Yoshimura, M. Liu, et al. 2013. Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages. Cancer Research 73: 550-560.
13. Kim, H.K., H. Zhang, H. Li, T.T.Wu, S. Swisher, D. He, et al. 2008. Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. Neoplasia 10: 1411-1420.
14. He, D., H. Li, N. Yusuf, C.A. Elmets, J. Li, J.D. Mountz, et al. 2010. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. Journal of Immunology 184: 2281-2288.
15. Kim, S.D., S. Kwon, S.K. Lee, M. Kook, H.Y. Lee, K.D. Song, et al. 2013. The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis. Experimental & Molecular Medicine 45: e40.
16. Holobotovskyy, V., M. Manzur, M. Tare, J. Burchell, E. Bolitho, H. Viola, et al. 2013. Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling. Circulation Research 112: 781-791.
17. Wang, G., M. Tschoi, R. Spolski, Y. Lou, K. Ozaki, C. Feng, et al. 2003. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Research 63: 9016-9022.
18. Gabrilovich, D.I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews Immunology 9: 162-174.
19. Marigo, I., L. Dolcetti, P. Serafini, P. Zanovello, and V. Bronte. 2008. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunological Reviews 222: 162-179.
20. Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-arginine metabolism. Nature Reviews Immunology 5: 641-654.
21. Maghazachi, A.A., A. al-Aoukaty, and T.J. Schall. 1994. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins. Journal of Immunology 153: 4969-4977.
22. Sebok, K., D.Woodside, A. al-Aoukaty, A.D. Ho, S. Gluck, and A.A. Maghazachi. 1993. IL-8 induces the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide binding (Go) protein. Journal of immunology 150: 1524-1534.
23. Scharton-Kersten, T., and P. Scott. 1995. The role of the innate immune response in Th1 cell development following Leishmania major infection. Journal of Leukocyte Biology 57: 515-522.
24. Le, Y., W. Gong, B. Li, N.M. Dunlop, W. Shen, S.B. Su, et al. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. Journal of Immunology 163: 6777-6784.
25. Dahlgren, C., T. Christophe, F. Boulay, P.N. Madianos, M.J. Rabiet, and A. Karlsson. 2000. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95: 1810-1818.
26. Pohajdak, B., J. Gomez, F.W. Orr, N. Khalil, M. Talgoy, and A.H. Greenberg. 1986. Chemotaxis of large granular lymphocytes. Journal of Immunology 136: 278-284.
27. Ruth, J.H., C.S. Haas, C.C. Park, M.A. Amin, R.J. Martinez, G.K. Haines 3rd, et al. 2006. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis and Rheumatism 54: 765-778.
28. Serafini, P., I. Borrello, and V. Bronte. 2006.Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Seminars in Cancer Biology 16: 53-65.
29. Joyce, J.A., and J.W. Pollard. 2009.Microenvironmental regulation of metastasis. Nature Reviews Cancer 9: 239-252.
30. Gordon, S., and P.R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nature Reviews Immunology 5: 953-964.
31. Talmadge, J.E., M. Donkor, and E. Scholar. 2007. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Reviews 26: 373-400.
32. Mosser, D.M., and J.P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 8: 958-969.
33. Afonina, I.S., S.P. Cullen, and S.J. Martin. 2010. Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunological Reviews 235: 105-116.
34. Schwarz, E.C., B. Qu, and M. Hoth. 1833. Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells. Biochimica et Biophysica acta 2013: 1603-1611.
35. Azogui, O., M.F. Avril, A. Margulis, M. Guillard, B. Caillou, and M. Prade. 1991. Tumor-infiltrating CD3- NK cells aremore effective than CD3+ T cells in killing autologous melanoma cells. The Journal of Investigative Dermatology 97: 425-429.
36. Vesely, M.D., M.H. Kershaw, R.D. Schreiber, and M.J. Smyth. 2011. Natural innate and adaptive immunity to cancer. Annual Review of Immunology 29: 235-271.
37. Schroder, K., M.J. Sweet, and D.A. Hume. 2006. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 211: 511-524.
38. Kang, H.K., H.Y. Lee, M.K. Kim, K.S. Park, Y.M. Park, J.Y. Kwak, et al. 2005. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. Journal of Immunology 175: 685-692.